Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001062993-22-008141
Filing Date
2022-03-18
Accepted
2022-03-18 17:14:40
Documents
1
Period of Report
2021-03-03

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.html 4  
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.xml 4 7982
  Complete submission text file 0001062993-22-008141.txt   9364
Mailing Address 2735 SAND HILL ROAD MENLO PARK CA 94025
Business Address
ROOT JONATHAN D (Reporting) CIK: 0001225480 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39756 | Film No.: 22753417

Mailing Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109
Business Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109 206-456-2900
Silverback Therapeutics, Inc. (Issuer) CIK: 0001671858 (see all company filings)

EIN.: 811489190 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations